Chau, Marisa
MRC Clinical Trials Unit at UCL · University College London
3 papers on CoChatORCID 0000-0003-2965-1870
Most cited papers
- Verified
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The ‘Exenatide-PD3’ study
Vijiaratnam, N., Girges, C., Auld, G., Chau, M., Maclagan, K., King, A., Skene, S., Chowdhury, K., Hibbert, S., Morris, H., et al. (2021) · BMJ Open
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 84
- Verified
Investigation of bias in meta-analyses due to selective inclusion of trial effect estimates: empirical study
Page, M. J., Forbes, A., Chau, M., Green, S. E., & McKenzie, J. E. (2016) · BMJ Open
Meta-analysis and systematic reviewsPharmaceutical industry and healthcare
Cited by 23
- Verified
Searches for evidence mapping: effective, shorter, cheaper
Parkhill, A. F., Clavisi, O., Pattuwage, L., Chau, M., Turner, T., Bragge, P., & Gruen, R. (2011) · Journal of the Medical Library Association : JMLA
Meta-analysis and systematic reviewsHealth Sciences Research and Education
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free